Agenus, Inc. (AGEN)
8.34
+0.67
(+8.74%)
USD |
NASDAQ |
Aug 25, 16:00
8.34
0.00 (0.00%)
After-Hours: 16:22
Agenus Price : 8.34 for Aug. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 8.07 | 8.07 | 7.60 | 7.67 | 775158.0 |
| Aug 21, 2026 | 7.58 | 8.35 | 7.577 | 8.09 | 1.518M |
| Aug 20, 2026 | 8.22 | 8.25 | 7.31 | 7.49 | 1.576M |
| Aug 19, 2026 | 7.66 | 8.735 | 7.620 | 8.26 | 2.290M |
| Aug 18, 2026 | 7.13 | 7.645 | 7.08 | 7.53 | 967559.0 |
| Aug 17, 2026 | 7.30 | 7.305 | 6.960 | 7.15 | 831412.0 |
| Aug 14, 2026 | 6.93 | 7.46 | 6.83 | 7.32 | 1.252M |
| Aug 13, 2026 | 6.85 | 7.03 | 6.71 | 7.00 | 624952.0 |
| Aug 12, 2026 | 6.91 | 7.20 | 6.83 | 6.90 | 1.154M |
| Aug 11, 2026 | 6.84 | 6.895 | 6.42 | 6.83 | 1.374M |
| Aug 10, 2026 | 6.83 | 7.09 | 6.36 | 7.00 | 1.923M |
| Aug 07, 2026 | 7.52 | 7.550 | 6.92 | 6.96 | 1.191M |
| Aug 06, 2026 | 7.67 | 8.85 | 7.323 | 7.49 | 2.455M |
| Aug 05, 2026 | 8.35 | 8.524 | 7.690 | 7.78 | 1.457M |
| Aug 04, 2026 | 7.85 | 8.38 | 7.75 | 8.30 | 2.017M |
| Aug 03, 2026 | 7.65 | 8.09 | 7.50 | 7.82 | 1.654M |
| Jul 31, 2026 | 7.79 | 7.98 | 7.32 | 7.50 | 1.574M |
| Jul 30, 2026 | 6.77 | 7.99 | 6.51 | 7.91 | 3.003M |
| Jul 29, 2026 | 6.61 | 6.95 | 6.484 | 6.63 | 1.857M |
| Jul 28, 2026 | 6.06 | 6.64 | 5.88 | 6.60 | 2.785M |
| Jul 27, 2026 | 5.99 | 6.20 | 5.87 | 6.13 | 1.234M |
| Jul 24, 2026 | 6.20 | 6.23 | 5.81 | 5.98 | 1.249M |
| Jul 23, 2026 | 5.53 | 6.225 | 5.46 | 6.19 | 2.333M |
| Jul 22, 2026 | 5.57 | 5.89 | 5.50 | 5.53 | 1.699M |
| Jul 21, 2026 | 5.00 | 5.90 | 4.99 | 5.58 | 2.603M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Iovance Biotherapeutics, Inc. | 8.445 |
| Novavax, Inc. | 9.44 |
| Fate Therapeutics, Inc. | 2.545 |
| Amgen, Inc. | 442.54 |
| Anika Therapeutics, Inc. | 21.52 |
Price Related Metrics
| PE Ratio | 3.146 |
| PS Ratio | 2.322 |
| Earnings Yield | 31.79% |
| Market Cap | 355.41M |
| Operating PE Ratio | 8.588 |
| Normalized PE Ratio | 8.355 |